Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phosphatidic acid (PA) generation pathway is a critical lipid signaling network responsible for the production of PA, a key second messenger and structural component of cell membranes (Wang et al., 2006, PMID: 16902574). PA is primarily generated through two major enzymatic routes: the hydrolysis of phosphatidylcholine by phospholipase D (PLD1 and PLD2) and the phosphorylation of diacylglycerol by diacylglycerol kinases (DGKs) (Foster, 2009, PMID: 19114011). As a signaling molecule, PA directly interacts with and activates various effector proteins, such as mTOR, Raf-1 kinase, and several protein kinase C (PKC) isoforms, thereby regulating essential cellular processes including growth, proliferation, and vesicular trafficking (Zhen et al., 2021, PMID: 33553412). In pathological contexts, overactivation of the PA generation pathway is linked to cancer progression, metastasis, and inflammatory responses, making its constituent enzymes attractive therapeutic targets (Bruntz et al., 2014, PMID: 24923870). Pharmacological modulation of this pathway typically involves small-molecule inhibitors of PLD or DGK, which are being explored for their potential to suppress tumor growth and modulate immune cell function (Gomez-Cambronero, 2014, PMID: 24497475). Therapeutic challenges include the potential for broad metabolic disruption given PA's fundamental role in membrane structure and diverse signaling contexts.
Small-molecule inhibition of enzymes within the pathway, such as Phospholipase D (PLD) or Diacylglycerol kinase (DGK), prevents the conversion of precursor lipids into phosphatidic acid, thereby blocking the recruitment and activation of downstream signaling effectors like mTOR and Raf-1.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidic acid generation pathway (PA pathway).